author-photo

Ziad Younes

9

Papers

268

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Andecaliximab [Anti-matrix Metalloproteinase-9] induction therapy for ulcerative colitis: A randomised, double-blind, placebo-controlled, phase 2/3 study in patients with moderate to severe disease

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (19)
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (18)
Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial

2011 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (123)
Induction Therapy with Certolizumab Pegol in Patients with Moderate to Severe Crohnʼs Disease: A Placebo-Controlled Trial: 1156

2010 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (5)
Anasarca and small bowel obstruction secondary to endometriosis.

2001 Journal of Clinical Gastroenterology
Show All
- Source
- Cite
- Save
Citations (26)